» Articles » PMID: 21594769

Progression from First Symptom to Diagnosis in Childhood Brain Tumours

Overview
Journal Eur J Pediatr
Specialty Pediatrics
Date 2011 May 20
PMID 21594769
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

This study was undertaken to investigate the evolution of clinical features between onset of symptoms and diagnosis in children with brain tumours and to identify ways of shortening the time to diagnosis. One hundred and thirty-nine children with a brain tumour were recruited from four UK paediatric neuro-oncology centres. Children had a median of one symptom or sign at symptom onset and six by diagnosis. The symptoms and/or signs experienced at symptom onset and at diagnosis were as follows: headache in 55 and 81 children, nausea and vomiting in 39 and 88 children, motor system abnormalities in 31 and 93 children, cranial nerve palsies in 24 and 75 children, visual system abnormalities in 23 and 96 children, endocrine or growth abnormalities in 10 and 35 children and behavioural change in 4 and 55 children. The median time between symptom onset and diagnosis (symptom interval) was 3.3 months. A longer symptom interval was associated with head tilt, cranial nerve palsies, endocrine and growth abnormalities and reduced visual acuity. More than half of children with brain tumours developed problems with vision and more than a third developed motor problems, cranial nerve palsies, behavioural change, or nausea and vomiting between symptom onset and diagnosis.

Citing Articles

Impact of the SARS-CoV-2/COVID-19 pandemic on the patient journeys of those with a newly diagnosed paediatric brain tumour in the UK: a qualitative study.

Akhter K, Casson R, Brewster L, Burke G, Kilday J, Macarthur D BMJ Open. 2025; 15(1):e086118.

PMID: 39753258 PMC: 11749440. DOI: 10.1136/bmjopen-2024-086118.


Evaluation of Pathway to Diagnosis of Pediatric Brain Tumors in Tamil Nadu, India.

Kartik P, Liu J, Sudarsan R, Srinivasan A, Jayaraman D, Sivaprakasam P JCO Glob Oncol. 2024; 10:e2300214.

PMID: 38386953 PMC: 10898677. DOI: 10.1200/GO.23.00214.


Musculoskeletal misdiagnoses in children with brain tumors: A nationwide, multicenter case-control study.

Hallundbaek L, Hagstrom S, Mathiasen R, Herlin T, Hasle H, Weile K PLoS One. 2023; 18(6):e0279549.

PMID: 37352313 PMC: 10289381. DOI: 10.1371/journal.pone.0279549.


Neuroimaging to diagnose central nervous system tumours in children.

Cheng S, Goldman R Can Fam Physician. 2023; 69(3):165-167.

PMID: 36944513 PMC: 10030132. DOI: 10.46747/cfp.6903165.


Childhood brain tumors: It is the child's brain that really matters.

Walker D Front Oncol. 2022; 12:982914.

PMID: 36267979 PMC: 9576866. DOI: 10.3389/fonc.2022.982914.


References
1.
Cohen M, Duffner P, HEFFNER R, Lacey D, Brecher M . Prognostic factors in brainstem gliomas. Neurology. 1986; 36(5):602-5. DOI: 10.1212/wnl.36.5.602. View

2.
Linet M, Ries L, Smith M, Tarone R, Devesa S . Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst. 1999; 91(12):1051-8. DOI: 10.1093/jnci/91.12.1051. View

3.
Akyuz C, Emir S, Akalan N, Soylemezoglu F, Kutluk T, Buyukpamukcu M . Intracranial ependymomas in childhood--a retrospective review of sixty-two children. Acta Oncol. 2001; 39(1):97-100. DOI: 10.1080/028418600431049. View

4.
Wilne S, Ferris R, Nathwani A, Kennedy C . The presenting features of brain tumours: a review of 200 cases. Arch Dis Child. 2006; 91(6):502-6. PMC: 2082784. DOI: 10.1136/adc.2005.090266. View

5.
Halperin E, Watson D, George S . Duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastoma. Cancer. 2001; 91(8):1444-50. DOI: 10.1002/1097-0142(20010415)91:8<1444::aid-cncr1151>3.0.co;2-u. View